ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Retrophin Completes Acquisition of Orphan Technologies americanpharmaceuticalreview
November 25, 2020Retrophin announced the completion of its previously announced acquisition of Orphan Technologies Limited, a privately held, clinical-stage biopharmaceutical company focused on the development of product candidate OT-58 for the treatment of classical ... -
Retrophin to Acquire Orphan Technologies americanpharmaceuticalreview
October 26, 2020Retrophin has entered into a definitive agreement to acquire Orphan Technologies, a privately held, clinical-stage biopharmaceutical company focused on the development of product candidate OT-58 for the treatment of classical homocystinuria (HCU).
Pharma Sources Insight January 2025
